Medical Researches
Questionable
Based on 10 Researches
L-Carnosine reduces anxiety in autismOral Supplementation of L-Carnosine Attenuates Acute-Stress-Induced Corticosterone Release and Mitigates Anxiety in CD157 Knockout Mice.
Study directly addresses autism
We assessed the impact of L-carnosine on anxiety behaviors in a specific mouse model of autism spectrum disorder (ASD). This study focused on CD157 knockout (KO) mice, which exhibit characteristics relevant to autism.
Interestingly, we observed that oral supplementation of L-carnosine effectively reduced the release of corticosterone, a stress hormone, in response to acute stress situations. This hormone is essential in understanding stress-related disorders, including anxiety.
Furthermore, our findings highlight that L-carnosine appears to alleviate anxiety-like behaviors in these mice. This suggests that by regulating stress responses, L-carnosine could potentially serve as a beneficial supplement for individuals with ASD experiencing anxiety.
Read More
L-carnosine may aid social deficitsOral Supplementation with L-Carnosine Attenuates Social Recognition Deficits in CD157KO Mice via Oxytocin Release.
Highly relevant to ASD research
We examined the effects of L-carnosine, a dietary supplement, on social deficits in CD157KO mice, which model some behaviors seen in autism spectrum disorder (ASD). In tests designed to measure social behavior, we found that oral supplementation with L-carnosine helped reduce these social deficits.
Interestingly, after the treatment, there was an increase in specific neurons related to oxytocin production in the brain, particularly in areas linked to social behavior. Although L-carnosine didn’t change the overall levels of oxytocin and its receptors in one part of the brain, it did increase oxytocin concentrations in the cerebrospinal fluid of the mice.
These findings suggest that L-carnosine supplementation might help enhance social recognition by boosting oxytocin levels. This aligns with the ongoing search for safe nutritional interventions to assist individuals with autism in our society.
Read More
We investigated how l-carnosine might help counteract the neurotoxic effects of propionic acid (PA), a substance linked to autism. Our study employed a controlled design, where we compared various groups of Syrian hamsters, including those treated with PA, clindamycin-induced PA, and those given carnosine and carnitine as potential protective supplements.
During the experiment, we monitored levels of important neurotransmitters like dopamine and GABA in several parts of the brain. We observed promising results showing that both carnosine and carnitine could reduce the negative impacts of PA on the brain. While these findings are encouraging, it's crucial to note that we did not test l-carnosine’s direct effects specifically in treating autism, nor did we find evidence that linked it to improvements in autistic behaviors.
Read More
We observed a growing interest in l-carnosine as a potential treatment for autism, focusing on how it might alleviate some of the symptoms associated with this condition. Through double-blind, placebo-controlled trials, researchers investigated the effects of this antioxidant on autistic behavior.
The promising aspect of these studies is that they highlighted significant improvements in behavior when participants took l-carnosine. Additionally, indirect markers of oxidative stress, which appear to be higher in individuals with autism, were addressed. The idea is that by reducing oxidative stress in the body, l-carnosine may help support brain function and overall well-being.
However, while the results point towards benefits, more research is needed to fully understand how effective l-carnosine can be in the long term and across different individuals. Overall, our exploration into this antioxidant's role in treating autism is an exciting step towards finding new avenues for support and intervention.
Read More
l-Carnosine enhances sleep qualityEffects of l-Carnosine Supplementation on Sleep Disorders and Disease Severity in Autistic Children: A Randomized, Controlled Clinical Trial.
Directly evaluates l-carnosine impacts
We conducted a double-blind, randomized clinical trial to investigate how l-carnosine supplementation affects sleep disorders and the severity of autism in children. Our study involved 43 autistic participants, aged between 4 and 16 years, who were divided into two groups—one receiving 500 mg of l-carnosine daily and the other receiving a placebo for two months.
While we found that l-carnosine supplementation did not significantly change the overall severity of autism symptoms or anthropometric measures, it did lead to some interesting results regarding sleep. Specifically, we observed a notable reduction in sleep duration and parasomnias, as well as a decrease in the total sleep disorder score among those receiving l-carnosine compared to the control group.
These findings suggest that l-carnosine may be beneficial for improving certain sleep disturbances common in autistic children. However, it is important to note that while we saw improvements in sleep-related issues, the core symptoms of autism remained unaffected.
Read More